financetom
Business
financetom
/
Business
/
Reddit Stock's Late-In-The-Day Surge: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reddit Stock's Late-In-The-Day Surge: What's Going On?
Mar 17, 2025 1:51 PM

Reddit Inc. ( RDDT ) shares traded briefly higher on Monday after Google announced an expanded partnership with the social media platform.

What To Know: According to Reuters, the agreement will integrate Reddit ( RDDT ) content more effectively across Google’s products, signaling a closer relationship between the two companies amid concerns that Reddit’s user growth is heavily reliant on Google Search traffic.

Despite the stock’s modest gain, Redburn Atlantic analyst James Cordwell initiated coverage on Reddit ( RDDT ) with a Sell rating, citing vulnerabilities in its daily active user growth due to potential algorithm shifts by Google.

Cordwell set a price target of $75, significantly below the current trading price, potentially raising concerns about the long-term sustainability of Reddit’s traffic-driven business model.

The conflicting signals between Google’s deeper involvement and analyst skepticism highlight the uncertainty surrounding Reddit's ( RDDT ) growth trajectory. While the company benefits from increased visibility on Google’s platforms, reliance on search algorithms remains a risk.

RDDT Price Action: Reddit ( RDDT ) shares closed down 2.07% at $125.56 at publication Monday, according to Benzinga Pro.

Read Next:

Wall Street Wavers On Mixed Retail Sales, Nvidia Falls Ahead Of GTC AI Conference, Intel Rallies: What’s Driving Markets Monday?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Ellison Plans to Consolidate Paramount Cable, Broadcast Units, Trim CEO Trio
Update: Market Chatter: Ellison Plans to Consolidate Paramount Cable, Broadcast Units, Trim CEO Trio
Dec 4, 2024
08:07 AM EST, 12/04/2024 (MT Newswires) -- (Update with Paramount's response to a request for comment.) Incoming Paramount Global ( PARAA ) Chief Executive David Ellison is considering consolidating the company's TV networks and overhauling top management, Bloomberg reported Tuesday, citing people familiar with the matter. Ellison will take over as CEO when Paramount merges with Skydance Media next year,...
Relmada Therapeutics' Late-Stage Trial of REL-1017 Deemed 'Futile' -- Shares Decline Pre-Bell
Relmada Therapeutics' Late-Stage Trial of REL-1017 Deemed 'Futile' -- Shares Decline Pre-Bell
Dec 4, 2024
08:05 AM EST, 12/04/2024 (MT Newswires) -- Relmada Therapeutics Inc ( RLMD ) said Wednesday that an Independent Data Monitoring Committee has determined that a late-stage study of REL-1017 as an adjunctive treatment for major depressive disorder is futile. The committee said trial is unlikely to meet the primary efficacy endpoint with statistical significance. We are disappointed with the outcome...
Scotiabank Previews Wednesday's Canada Labor Productivity for Q3
Scotiabank Previews Wednesday's Canada Labor Productivity for Q3
Dec 4, 2024
08:06 AM EST, 12/04/2024 (MT Newswires) -- Canada is scheduled to release the labor productivity data for Q3 at 8:30 a.m. ET on Wednesday, noted Scotiabank. Q3 labor productivity is expected to extend the decline to seven out of the past eight quarterly readings, stated the bank. ...
Update: Eli Lilly Says its Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial
Update: Eli Lilly Says its Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial
Dec 4, 2024
08:05 AM EST, 12/04/2024 (MT Newswires) -- (Updates with additional details in the third, fourth and fifth paragraphs and latest stock movement in the sixth paragraph.) Eli Lilly ( LLY ) said Wednesday its Surmount-5 phase 3b clinical study showed its Zepbound provided a 47% greater relative weight loss in comparison to Novo Nordisk's ( NVO ) Wegovy. Zepbound resulted...
Copyright 2023-2026 - www.financetom.com All Rights Reserved